There’s some caveats here, breast cancer kills women at an older age than prostate cancer kills men. Breast cancer kills 19.3 per 100k, prostate cancer kills 19.0 per 100k, however this again ignores that men are far more likely to die from heart disease or stroke long before any cancer forms. The funding is always 2-3:1 for breast cancer and prostate cancer respectively. There’s also the fact that breast cancer gets grifted as far higher rates per dollar spent, the Komen foundation was notorious for essentially money laundering their donations into their “expenses”.
the National Institutes of Health (NIH) spends almost three times more on breast cancer research ( $700 million) than on prostate cancer research ($250 million)
You've made the point about perfectly. All that I would add is the weaknesses of prostate antigen testing. Essentially it's just looking for immunological signs of prostate tissue in the blood as opposed to the prostate, a sign of cancer. Other things can cause this and the rate of false diagnoses is high enough that even investigating for prostate cancer is discouraged until men are of advanced age. Biopsies are more resource intensive, so most systems, universal or private, make an effort to frustrate people out of bothering.
Because of the lack of dialogue, there's not much being done for more reliable screening where women have mammograms and blood work that can detect it and confirm it.
There’s some caveats here, breast cancer kills women at an older age than prostate cancer kills men. Breast cancer kills 19.3 per 100k, prostate cancer kills 19.0 per 100k, however this again ignores that men are far more likely to die from heart disease or stroke long before any cancer forms. The funding is always 2-3:1 for breast cancer and prostate cancer respectively. There’s also the fact that breast cancer gets grifted as far higher rates per dollar spent, the Komen foundation was notorious for essentially money laundering their donations into their “expenses”.
I recall they tried to trademark the color pink.
You've made the point about perfectly. All that I would add is the weaknesses of prostate antigen testing. Essentially it's just looking for immunological signs of prostate tissue in the blood as opposed to the prostate, a sign of cancer. Other things can cause this and the rate of false diagnoses is high enough that even investigating for prostate cancer is discouraged until men are of advanced age. Biopsies are more resource intensive, so most systems, universal or private, make an effort to frustrate people out of bothering.
Because of the lack of dialogue, there's not much being done for more reliable screening where women have mammograms and blood work that can detect it and confirm it.